1240190-21-9

Basic information

• Product Name: (R)-2-butyl-N₄-hydroxy-N₁-[(3-m-trifluoromethylphenylisoxazol-5-yl)-methyl]succinamide
• CAS NO: 1240190-21-9
• Molecular Weight: 413.397
• Mol File: 1240190-21-9.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: (R)-2-butyl-N₄-hydroxy-N₁-[(3-m-trifluoromethylphenylisoxazol-5-yl)-methyl]succinamide(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-2-butyl-N₄-hydroxy-N₁-[(3-m-trifluoromethylphenylisoxazol-5-yl)-methyl]succinamide(1240190-21-9)
• EPA Substance Registry System: (R)-2-butyl-N₄-hydroxy-N₁-[(3-m-trifluoromethylphenylisoxazol-5-yl)-methyl]succinamide(1240190-21-9)

Safety Data

• Hazardous Substances Data: 1240190-21-9(Hazardous Substances Data)

Upstream product

• 1240190-02-6 5-aminomethyl-3-m-trifluoromethylphenylisoxazole 
• 1240190-09-3 N-[(3-m-trifluoromethylphenylisoxazol-5-yl)-methyl]-(R)-2-tert-butoxycarbonylmethylhexanamide 
• 1240190-15-1 N-[(3-m-trifluoromethylphenylisoxazol-5-yl)methyl]-(R)-2-methoxycarbonylmethylhexanamide 
• 368-83-2 3-(trifluoromethyl)benzaldehyde oxime 
• 454-89-7 3-Trifluoromethylbenzaldehyde 

Relevant articles and documents

Synthesis and preliminary antibacterial evaluation of 2-butyl succinate-based hydroxamate derivatives containing isoxazole rings

Two series of novel 2-butyl succinate-based Hydroxamate derivatives containing isoxazole rings were synthesized, characterized and evaluated for antibacterial activity. The synthesized compounds were found to exhibit weak to moderate inhibitory activity against Staphytlococcus aureu and Klebsiellar pneumonia in vitro. All the compounds synthesized were found to be more effective against Klebsiellar pneumonia compared to Staphytlococcus aureu.